- FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive Order fda.gov
- U.S. FDA plans ultra-fast review of three psychedelic drugs following Trump directive CTV News
- FDA grants quick review for 3 psychedelic drug trials NBC News
- Ibogaine is drawing new interest from the Trump administration. Here’s what to know about the psychedelic CNN
- FDA Gives Three Vouchers for Faster Psychedelic Approvals Bloomberg.com
Add Comment